Development of Potential Antitumor Agents. Synthesis and Biological Evaluation of a New Set of Sulfonamide Derivatives as Histone Deacetylase Inhibitors

A series of sulfonamide hydroxamic acids and anilides have been synthesized and studied as histone deacetylase (HDAC) inhibitors that can induce hyperacetylation of histones in human cancer cells. The inhibition of HDAC activity represents a novel approach for intervening in cell cycle regulation. T...

Full description

Saved in:
Bibliographic Details
Published inJournal of medicinal chemistry Vol. 46; no. 5; pp. 820 - 830
Main Authors Bouchain, Giliane, Leit, Silvana, Frechette, Sylvie, Khalil, Elie Abou, Lavoie, Rico, Moradei, Oscar, Woo, Soon Hyung, Fournel, Marielle, Yan, Pu T, Kalita, Ann, Trachy-Bourget, Marie-Claude, Beaulieu, Carole, Li, Zuomei, Robert, Marie-France, MacLeod, A. Robert, Besterman, Jeffrey M, Delorme, Daniel
Format Journal Article
LanguageEnglish
Published WASHINGTON American Chemical Society 27.02.2003
Amer Chemical Soc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A series of sulfonamide hydroxamic acids and anilides have been synthesized and studied as histone deacetylase (HDAC) inhibitors that can induce hyperacetylation of histones in human cancer cells. The inhibition of HDAC activity represents a novel approach for intervening in cell cycle regulation. The lead candidates were screened in a panel of human tumor and normal cell lines. They selectively inhibit proliferation, cause cell cycle blocks, and induce apoptosis in human cancer cells but not in normal cells. The structure−activity relationships, the antiproliferative activity, and the in vivo efficacy are described.
Bibliography:istex:305AB5921BE2E57860DFD61BFA86065A87F793F6
ark:/67375/TPS-N62LVZ2V-M
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0022-2623
1520-4804
DOI:10.1021/jm020377a